InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Mason Michael, Chief Financial Officer. Officer active across 1 companies, notably Karyopharm Therapeutics Inc.. Aggregated, 6 filings have been published. Total volume traded: €71k. The latest transaction was disclosed on 3 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€3,360598 shares@ €5.6180.0019% mcap4.7% of flow
Common Stock
SEC:0000899243-22-021234:0·
088,200 shares0
Common Stock
SEC:0001209191-22-014628:0·
€33,9813,947 shares@ €8.60920.020% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008126·
€33,9813,947 shares@ €8.60920.020% mcap47.6% of flow
Common Stock
SEC:0001209191-22-008126:0·
05,500 shares0
Common Stock
SEC:0000899243-21-021368·
05,500 shares0
Common Stock
SEC:0000899243-21-021368:0·
6 of 6 declarations
About Mason Michael
Michael Mason is the Chief Financial Officer at Karyopharm Therapeutics Inc. In this role, he oversees the company's financial operations and participates in overall strategy. Karyopharm Therapeutics Inc. is a biopharmaceutical company specializing in developing innovative treatments. Michael Mason brings valuable financial expertise to support the company's growth and sustainability.
